CN109862904A - 杆菌肽-藻酸盐低聚物缀合物 - Google Patents

杆菌肽-藻酸盐低聚物缀合物 Download PDF

Info

Publication number
CN109862904A
CN109862904A CN201780065048.2A CN201780065048A CN109862904A CN 109862904 A CN109862904 A CN 109862904A CN 201780065048 A CN201780065048 A CN 201780065048A CN 109862904 A CN109862904 A CN 109862904A
Authority
CN
China
Prior art keywords
bacitracin
alginate oligomer
alginate
acid
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780065048.2A
Other languages
English (en)
Chinese (zh)
Inventor
E·弗格森
D·W·托马斯
A·德森
P·赖伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Algipharma AS
Original Assignee
Algipharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algipharma AS filed Critical Algipharma AS
Publication of CN109862904A publication Critical patent/CN109862904A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C07K7/58—Bacitracins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
CN201780065048.2A 2016-10-21 2017-10-20 杆菌肽-藻酸盐低聚物缀合物 Pending CN109862904A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1617862.6 2016-10-21
GB1617862.6A GB2555391B (en) 2016-10-21 2016-10-21 Bacitracin-alginate oligomer conjugates
PCT/EP2017/076926 WO2018073448A1 (en) 2016-10-21 2017-10-20 Bacitracin-alginate oligomer conjugates

Publications (1)

Publication Number Publication Date
CN109862904A true CN109862904A (zh) 2019-06-07

Family

ID=57738026

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780065048.2A Pending CN109862904A (zh) 2016-10-21 2017-10-20 杆菌肽-藻酸盐低聚物缀合物

Country Status (16)

Country Link
US (1) US20230139922A1 (cg-RX-API-DMAC7.html)
EP (1) EP3528829B1 (cg-RX-API-DMAC7.html)
JP (1) JP7191014B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190070946A (cg-RX-API-DMAC7.html)
CN (1) CN109862904A (cg-RX-API-DMAC7.html)
AU (1) AU2017345294A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019007928A2 (cg-RX-API-DMAC7.html)
CA (1) CA3040796A1 (cg-RX-API-DMAC7.html)
DK (1) DK3528829T3 (cg-RX-API-DMAC7.html)
ES (1) ES2914784T3 (cg-RX-API-DMAC7.html)
GB (1) GB2555391B (cg-RX-API-DMAC7.html)
PL (1) PL3528829T3 (cg-RX-API-DMAC7.html)
PT (1) PT3528829T (cg-RX-API-DMAC7.html)
RU (1) RU2766345C2 (cg-RX-API-DMAC7.html)
SI (1) SI3528829T1 (cg-RX-API-DMAC7.html)
WO (1) WO2018073448A1 (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111420024A (zh) * 2020-04-07 2020-07-17 中国科学院深圳先进技术研究院 杆菌酞a在制备预防和治疗冠状病毒的药物中的应用
CN112812150A (zh) * 2021-01-29 2021-05-18 深圳海创生物科技有限公司 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用
CN113413490A (zh) * 2021-05-14 2021-09-21 哈尔滨医科大学 一种超声响应性复合水凝胶及其制备方法和应用
CN117679350A (zh) * 2023-12-13 2024-03-12 诺德溯源(广州)生物科技有限公司 一种淡化痘印和抚平痘坑的愈创木组合物及其应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12649000B2 (en) 2018-03-19 2026-06-09 Algipharma As Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers
CN110484473B (zh) * 2019-08-31 2022-08-19 暨南大学 一种促进鹤羽田戴尔福特菌在植物根际定殖的方法
CN111057131A (zh) * 2019-12-13 2020-04-24 上海市食品药品检验所 一种杆菌肽及其组分的分析方法
WO2026008878A1 (en) * 2024-07-04 2026-01-08 Algipharma As Antimycotic polyene-alginate oligomer conjugates

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458474A (zh) * 2009-06-03 2012-05-16 阿尔吉法玛公司 使用藻酸盐低聚物和抗生素治疗不动杆菌
CN103857440A (zh) * 2011-06-22 2014-06-11 维奥姆生物科学有限公司 基于缀合物的抗真菌和抗细菌前药

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US6248360B1 (en) * 2000-06-21 2001-06-19 International Health Management Associates, Inc. Complexes to improve oral absorption of poorly absorbable antibiotics
RU2527894C2 (ru) * 2007-11-27 2014-09-10 Альгифарма ИПР АС Использование альгинатных олигомеров в борьбе с биопленками
EP2161020A1 (en) * 2008-09-09 2010-03-10 Koninklijke Philips Electronics N.V. Chelating amphiphilic polymers
EP3220965A1 (en) * 2014-11-20 2017-09-27 University of Southern California Use of alginate formulation for intraincisional drug delivery

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458474A (zh) * 2009-06-03 2012-05-16 阿尔吉法玛公司 使用藻酸盐低聚物和抗生素治疗不动杆菌
CN103857440A (zh) * 2011-06-22 2014-06-11 维奥姆生物科学有限公司 基于缀合物的抗真菌和抗细菌前药

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111420024A (zh) * 2020-04-07 2020-07-17 中国科学院深圳先进技术研究院 杆菌酞a在制备预防和治疗冠状病毒的药物中的应用
WO2021203704A1 (zh) * 2020-04-07 2021-10-14 中国科学院深圳先进技术研究院 杆菌酞a在制备预防和治疗冠状病毒的药物中的应用
CN111420024B (zh) * 2020-04-07 2023-10-03 中国科学院深圳先进技术研究院 杆菌酞a在制备预防和治疗冠状病毒的药物中的应用
CN112812150A (zh) * 2021-01-29 2021-05-18 深圳海创生物科技有限公司 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用
CN113413490A (zh) * 2021-05-14 2021-09-21 哈尔滨医科大学 一种超声响应性复合水凝胶及其制备方法和应用
CN113413490B (zh) * 2021-05-14 2022-05-27 哈尔滨医科大学 一种超声响应性复合水凝胶及其制备方法和应用
CN117679350A (zh) * 2023-12-13 2024-03-12 诺德溯源(广州)生物科技有限公司 一种淡化痘印和抚平痘坑的愈创木组合物及其应用
CN117679350B (zh) * 2023-12-13 2024-06-07 诺德溯源(广州)生物科技有限公司 一种淡化痘印和抚平痘坑的愈创木组合物及其应用

Also Published As

Publication number Publication date
SI3528829T1 (sl) 2022-07-29
CA3040796A1 (en) 2018-04-26
ES2914784T3 (es) 2022-06-16
RU2019109728A (ru) 2020-11-23
EP3528829A1 (en) 2019-08-28
JP7191014B2 (ja) 2022-12-16
DK3528829T3 (da) 2022-05-30
RU2019109728A3 (cg-RX-API-DMAC7.html) 2021-02-16
US20230139922A1 (en) 2023-05-04
PL3528829T3 (pl) 2022-09-19
GB2555391B (en) 2019-06-26
GB2555391A (en) 2018-05-02
BR112019007928A2 (pt) 2019-07-02
KR20190070946A (ko) 2019-06-21
PT3528829T (pt) 2022-06-02
GB201617862D0 (en) 2016-12-07
AU2017345294A1 (en) 2019-05-02
RU2766345C2 (ru) 2022-03-15
JP2019535669A (ja) 2019-12-12
WO2018073448A1 (en) 2018-04-26
EP3528829B1 (en) 2022-03-02

Similar Documents

Publication Publication Date Title
EP3528830B1 (en) Polymyxin-alginate oligomer conjugates
EP3528829B1 (en) Bacitracin-alginate oligomer conjugates
JP5202763B2 (ja) アルギネートオリゴマーと抗生物質とによるアシネトバクター感染の治療
KR102223224B1 (ko) 이중으로 유도화된 키토산 나노입자 및 이의 제조 방법과 생체 내 유전자 도입을 위하여 이를 이용하는 방법
AU2016236172B2 (en) Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfunction
TWI694087B (zh) 多黏桿菌素衍生物及其用途
ES2983095T3 (es) Oligómeros de alginato para el tratamiento o prevención del sobrecrecimiento microbiano en el tracto intestinal
CN106029079A (zh) 藻酸盐低聚物在治疗囊性纤维化和与缺陷性cftr离子通道功能相关的其它疾病中的应用
US20220143210A1 (en) Hydrogel compositions and methods for treatement of malignancies
US10646579B2 (en) Complex comprising RNAi molecule and N-acetylated chitosan
HK40004581A (zh) 杆菌肽-藻酸盐低聚物缀合物
US20250352663A1 (en) Nanoclusters Functionalized with Adenosine Triphosphate or an Analogue and Their Use
HK40004580A (zh) 多粘菌素-藻酸盐低聚物缀合物
CN111630169A (zh) 用于治疗溃疡性结肠炎患者的组合物及其作为药物的用途
WO2026008878A1 (en) Antimycotic polyene-alginate oligomer conjugates
EP4725958A1 (en) Novel decapeptide and use thereof in antibacterial
KR20190092615A (ko) 전이 형성 및/또는 재발을 예방하는 데 사용하기 위한 다당류
CN121177198A (zh) 一种口服多药递送水凝胶、制备方法及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40004581

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190607

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 40004581

Country of ref document: HK